NCT05453617

Brief Summary

Weight regain after weight loss is a major problem in the treatment of obesity. Two novel types of intermittent fasting recently have received more attention: the 5:2 diet and time-restricted eating (TRE). TRE requires individuals to eat in a specified number of hours per day (typically 4 to 10 hours) without energy intake restriction. The 5:2 diet involves 5 feast days and 2 fast days per week; participants eat ad libitum without restriction on feast days while 25% of energy needs (approximately 500-800 kcal per day) are consumed on fast day. This randomized controlled trial aimed to evaluate the effect of TRE and the 5:2 diet on weight loss maintenance and cardiometabolic risk factors after a low-calorie diet in obese adults over 12 months compared to usual health care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
270

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 18, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

July 12, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2025

Completed
Last Updated

November 9, 2023

Status Verified

November 1, 2023

Enrollment Period

2.8 years

First QC Date

June 18, 2022

Last Update Submit

November 8, 2023

Conditions

Keywords

ObesityTime restricted eatingThe 5:2 dietWeight loss maintenance

Outcome Measures

Primary Outcomes (1)

  • Change in body weight over 12 months

    Baseline to months 12

Secondary Outcomes (16)

  • Change in body fat composition meassured by DEXA

    Baseline to months 12

  • Change in waist circumference

    Baseline to months 12

  • Change in body mass index

    Baseline to months 12

  • Change in liver fat

    Baseline to months 12

  • Change in systolic blood pressure

    Baseline to months 12

  • +11 more secondary outcomes

Study Arms (3)

The TRE group

EXPERIMENTAL

Participants in the TRE group will be instructed to eat during a window of 8 h/d (8 am to 4 pm).

Behavioral: Time-restricted eating

The 5:2 diet group

EXPERIMENTAL

Participants in the 5:2 diet group will be instructed to consume 500-600 kcal/d on fast days and eat ad libitum on feast days.

Behavioral: The 5:2 diet

Control

NO INTERVENTION

Participants in the control group will receive a general lifestyle counseling.

Interventions

Participants in the TRE group will be instructed to eat during a window of 8 h/d (8 am to 4 pm)

The TRE group
The 5:2 dietBEHAVIORAL

Participants will be instructed to consume 500-600 kcal/d on fast days and eat ad libitum on feast days.

The 5:2 diet group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Man or women aged 18-75 years;
  • Body mass index (BMI)of 28.0 to 45.0 kg/m2;

You may not qualify if:

  • \. History of HIV, hepatitis B or C (self-report) or active pulmonary tuberculosis;
  • \. Diagnosis of type 1 and type 2 diabetes;
  • \. History of malignant tumors;
  • \. Serious liver dysfunction or chronic kidney disease (AST or ALT \> 3 times the upper limit of normal, or eGFR\<30 ml/min/1.73 m2);
  • \. History of serious cardiovascular or cerebrovascular disease (angina, myocardial infarction or stroke) in the past 6 months;
  • \. History of severe gastrointestinal diseases or gastrointestinal surgery in the past 12 months;
  • \. History of Cushing's syndrome, hypothyroidism, acromegaly, hypothalamic obesity;
  • \. Being a smoker or having been a smoker in the 3 months prior to their screening visit;
  • \. Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic drugs or other medications as determined by the study physician;
  • \. Currently participating in weight loss programs or weight change in the past 3 months (\> 5% current body weight) ;
  • \. Women who are pregnant or plan to become pregnant;
  • \. Patients who cannot be followed for 24 months (due to a health situation or migration);
  • \. Patients who are unwilling or unable to give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, 510515, China

RECRUITING

MeSH Terms

Conditions

ObesityIntermittent Fasting

Interventions

Diet

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsFastingFeeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Huijie Zhang, MD. PhD.

    Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Huijie Zhang, MD. PhD.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 18, 2022

First Posted

July 12, 2022

Study Start

October 1, 2022

Primary Completion

July 15, 2025

Study Completion

July 15, 2025

Last Updated

November 9, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations